|
|
Article: Study data from Vanderbilt University, Medical Department provide new insights into radiopharmaceuticals.
- Article from:
- Drug Week
- Article date:
- November 20, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"A novel series of iodinated indomethacin derivatives was synthesized, and evaluated as selective inhibitors of COX-2. Two candidate compounds N-(p-iodobenzyl)-2-(1-(p-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetamide (3) and 1-(p-iodobenzyl)-5-methoxy-2-methyl-3-indoleacetic acid (9) possessed optimum properties suitable for potential in vivo imaging," researchers in the United States report (see also Radiopharmaceuticals).
"Arylstannane precursors for radioiododestannylation were synthesized in 70-85% yield from the iodo compounds by reaction with hexabutylditin and tetrakis(triphenylphosphine)palladium(0) in refluxing dioxane. Radioiododestannylation ...
Related newspaper, magazine, and journal articles:
|
|
Article: Investigators at Vanderbilt University, ...
Cancer Weekly;
September 22, 2009 ;
700+ words
... ... and colleagues, Vanderbilt University, Medical Department (see also Life ... G. Carpenter, Vanderbilt University, School Medical ... Cancer Research, Vanderbilt University, Medical Department. This article ...
|
|